Please assess the completion status of the following clinical trial:

Trial Title: Nonarthritic Hip Disease Evaluation And Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~Over 18 years old NAHD diagnosis~Exclusion Criteria:~* Osteoporosis or rheumatoid arthritis~* Systemic health condition~* Legal representative required for treatment decisions~* Bilateral symptoms~* Current spine, hip, knee, or ankle surgery or major injury\*~* Pregnancy~* Total hip arthroplasty candidate (Tönnis grade \> 2)~* Periacetabular osteotomy candidate (lateral center edge angle\<20, anterior center edge angle\<18, acetabular index \>10)~  * Participants with history of spine, hip, knee, or ankle surgery or major injury will be evaluated by the physician to determine appropriateness for evaluation (and treatment) by a physical therapist

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Interdisciplinary Evaluation (Type: EXPERIMENTAL): Participants will receive an Interdisciplinary Evaluation for Nonarthritic Hip Disease from a hip arthroscopist, followed by an examination from a physical therapist, and then will participate in a shared decision-making process with both providers to determine a plan of care.
- Standard Evaluation (Type: NO_INTERVENTION): Participants will receive a standard-of-care evaluation from a hip arthroscopist who will then determine the plan of care with the participant.
- Posture and Movement Training (Type: EXPERIMENTAL): Participants will receive six training sessions with a physical therapist over a 3-week period.
- 3-week Wait Period (Type: NO_INTERVENTION): Participants will undergo a 3-week wait period. They will be instructed to not receive any treatment (e.g. chiropractic services, physical therapy, medication, surgery, injections) for their hip symptoms during this time.
- Observational Arm (Type: OTHER): Participants who refuse randomization to receive posture and movement training may continue participation in an observational group. These participants complete the same baseline and follow-up testing but proceed with their treatment-of-choice during the 3-week intervention period.

Based on this trial design, predict the completion outcome and termination type (if applicable).